Iomeron (Iomeprol)

• Iomeron (iomeprol) is used as a radiographic contrast agent to improve X‑ray based imaging.
• Angiography: provides clear delineation of blood vessels for accurate diagnosis.
• Arthrography: enhances joint space visualization to assess cartilage and ligaments.
• Myelography: improves contrast of the spinal canal for detailed evaluation of neural structures.
• Other diagnostic imaging procedures requiring intra‑arterial, intra‑articular or intrathecal contrast: facilitates detailed anatomical assessment in specialized studies.

• Iomeprol contains multiple iodine atoms that strongly absorb X‑ray photons. When injected into vascular, joint or cerebrospinal spaces, the iodine increases attenuation of the X‑ray beam, creating radiodense areas that appear bright on the resulting images. This enhanced radiodensity allows clinicians to differentiate structures and detect pathology with greater clarity.

Adverse reactions to Iomeron can range from mild and transient to severe, though serious events are uncommon.

Common Side Effects

• Warmth or flushing sensation during injection
• Metallic taste in the mouth
• Nausea or mild vomiting

Serious or Rare Side Effects

• Severe allergic reaction (anaphylaxis) with respiratory distress
• Contrast‑induced nephropathy leading to acute kidney injury
• Significant hypotension or cardiovascular collapse

• Before using Iomeron, several safety considerations should be observed.
• Renal function assessment: evaluate serum creatinine and eGFR to identify risk of nephrotoxicity.
• Allergy screening: confirm no known iodine or contrast media hypersensitivity.
• Use lowest effective volume: limit exposure to the minimum required for diagnostic quality.
• Vital sign monitoring: observe blood pressure and heart rate during and after injection.
• Contraindication in severe hyperthyroidism: avoid use in uncontrolled thyroid disease.
• Store at ambient temperature: keep in original container, protect from light and moisture.

Iomeron may interact with other medicines, influencing safety or efficacy.

Major Interactions (Avoid)

• Concurrent nephrotoxic agents (e.g., aminoglycosides, high‑dose NSAIDs): increase risk of renal injury.
• Metformin in patients with reduced renal function: risk of lactic acidosis.
• Radioactive iodine therapy (I‑131): iodine load may interfere with treatment.

Moderate Interactions (Monitor Closely)

• Beta‑blockers: may mask contrast‑induced tachycardia.
• Diuretics: affect fluid balance and renal clearance.
• ACE inhibitors or ARBs: may potentiate renal effects, monitor kidney function.